Biotech news
Americas
Artificial intelligence is being used increasingly in the pharma and biotech industries, and questions are being asked about the legal status of innovations created by the technology, as MaryAnne Armstrong of Birch, Stewart, Kolasch & Birch reports. 31 May 2018
Asia
In India, there are two core areas of the antibody patenting field that are unsettled and need correcting, as Archana Shanker and Nupur Maithani of Anand and Anand explain. 31 May 2018
Asia-Pacific
UK-based Crescendo Biologics has agreed a global licensing deal with biopharma company Zai Lab which will see Zai Lab develop and commercialise an antibody, “VH domain therapeutic”, for applications in inflammatory diseases. 31 May 2018
Americas
The US government has required German company Bayer to divest $9 billion worth of business and assets in order to continue with its proposed $66 billion acquisition of US-based Monsanto. 30 May 2018
Americas
Animal health company Boehringer Ingelheim Vetmedica has sued Merck & Co and Merck Animal Health for infringing three patents covering vaccines for treating pig disease. 23 May 2018
Americas
Corteva Agriscience, the agriculture division of DowDuPont, has signed a licensing deal with Monsanto to use its technology for fighting insects found on corn. 23 May 2018
Pharma
The UK Intellectual Property Office has published several proposals, including some addressing barriers to growth for IP-rich companies, in response to received views of IP with regard to the government’s Industrial Strategy. 22 May 2018
Americas
US agriculture company Calyxt has announced it has resolved a licensing dispute over DNA-editing technology with Bayer CropScience. 17 May 2018
Pharma
UK-based law firm DLA Piper has announced that it will open a new office in Dublin, Ireland in light of Brexit. 16 May 2018
Americas
Eli Lilly has revealed plans to acquire Montreal-based AurKa Pharma, in what is the company’s second acquisition in less than one week. 15 May 2018